<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
May 2, 1997
-----------------------------------------------------
TRANSITIONAL HOSPITALS CORPORATION
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Nevada 1-7008 94-1599386
- ------------------------------- ------------ --------------
(State or other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification
Number)
5110 West Sahara Avenue, Las Vegas, Nevada 89102
-------------------------------------------------
(Address of Principal Executive Offices, Including ZIP code)
Registrant's telephone number, including area code (702) 259-3600
---------------
________________________________
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events
------------
On May 2, 1997 Transitional Hospitals Corporation, a Nevada corporation
(the "Corporation"), entered into an Agreement and Plan of Merger (the "Merger
Agreement") with Select Medical Corporation ("Parent") and SM Acquisition Co.
("Sub"), a copy of which is attached hereto as Exhibit 99.1 and incorporated
------------
herein by reference. Pursuant to the Merger Agreement, among other things, Sub
will be merged with and into the Corporation (the "Merger"). In the Merger each
of the shares of Common Stock of the Corporation, par value $1.00 per share (the
"Shares"), other than Shares held in the treasury of the Corporation or by
Parent or any subsidiary of the Corporation or Parent, will be converted into
the right to receive $14.55 in cash. Following the Merger the Corporation will
be a wholly owned subsidiary of Parent. The investment firms of Welsh, Carson,
Anderson & Stowe; Golder, Thoma, Cressy, Rauner; and Ferrar Freeman Thompson &
Co., Inc. have committed to provide the financing necessary to consummate the
Merger. A copy of such commitment is attached hereto as Exhibit 99.2 and
------------
incorporated herein by reference. Consummation of the Merger is subject to
receipt of all necessary consents and approvals, including the consent of the
holders of two-thirds of the outstanding Shares, and other customary conditions.
After the execution of the Merger Agreement the Corporation received a
letter from a major health care provider indicating that it was interested in
acquiring the Corporation in a transaction in which shareholders of the
Corporation would receive $15.00 per share. The Merger Agreement provides the
Corporation with certain rights to terminate the agreement in the event the
Corporation receives a more favorable offer. In such event the Corporation would
be obligated to pay Select approximately $19.4 million. There can be no
assurance that the major health care provider will make a firm offer to acquire
the Corporation for $15.00 per share or for any other price.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
------------------------------------------------------------------
(c) Exhibits
--------
99.1 Agreement and Plan of Merger dated May 2, 1997 between the
Corporation, Parent and Sub.
99.2 Letter dated May 2, 1997 to the Corporation from Welsh, Carson,
Anderson & Stowe; Golder, Thoma, Cressy, Rauner; and Ferrar Freeman
Thompson & Co., Inc.
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 5, 1997 TRANSITIONAL HOSPITALS CORPORATION
By: /S/ JULIA KOPTA
----------------------------------------------
Name: Julia Kopta
Title: General Counsel & Executive Vice President
-3-
<PAGE>
EXHIBIT 99.1
- --------------------------------------------------------------------------------
AGREEMENT AND PLAN OF MERGER
By and Among
Select Medical Corporation,
SM Acquisition Co.
and
Transitional Hospitals Corporation
Dated as of May 2, 1997
- --------------------------------------------------------------------------------
<PAGE>
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of May 2,
1997, is made by and among Select Medical Corporation, a Delaware corporation
("Parent"), SM Acquisition Co., a Nevada corporation and a wholly owned
subsidiary of Parent ("Sub"), and Transitional Hospitals Corporation, a Nevada
corporation ("Company").
WHEREAS, the Boards of Directors of Parent, Sub and Company deem it
advisable and in the best interests of their respective stockholders that Sub
merge with and into Company (the "Merger"), and such Boards of Directors have
approved the merger of Sub with and into Company upon the terms and subject to
the conditions set forth herein.
NOW, THEREFORE, in consideration of the foregoing and the respective
representations, warranties, covenants and agreements set forth herein, the
parties hereto agree as follows:
ARTICLE I
THE MERGER
Section 1.1 The Merger. Upon the terms and subject to the conditions
hereof, at the Effective Time (as defined in Section 1.2 hereof), Sub shall be
merged with and into Company and the separate corporate existence of Sub shall
thereupon cease, and Company shall be the surviving corporation in the Merger
(the "Surviving Corporation"). The Merger shall have the effects set forth in
Section 92A.250 of the General Corporation Law of the State of Nevada (the
"GCL").
Section 1.2 Effective Time of The Merger. The Merger shall be effective
when properly executed Articles of Merger ("Articles of Merger") are duly filed
with the Secretary of State of the State of Nevada, which filing shall be made
as soon as practicable after satisfaction or, to the extent permitted hereunder,
waiver of all of the conditions to each party's obligation to consummate the
Merger contained in Article VIII. When used in this Agreement, the term
"Effective Time" shall mean the date and time at which such Articles of Merger
are so filed.
ARTICLE II
THE SURVIVING CORPORATION
Section 2.1 Articles of Incorporation. Subject to Section 7.7 hereof, the
Articles of Incorporation of Sub in effect at the Effective Time shall be the
Articles of Incorporation of the Surviving Corporation.
1
<PAGE>
Section 2.2 By-Laws. Subject to Section 7.7 hereof, the by-laws of Sub as
in effect at the Effective Time shall be the By-Laws of the Surviving
Corporation.
Section 2.3 Directors and Officers of Surviving Corporation.
(a) The directors of Sub at the Effective Time shall be the initial
directors of the Surviving Corporation and shall hold office from the
Effective Time until their respective successors are duly elected or
appointed and qualify in the manner provided in the Articles of
Incorporation and by-laws of the Surviving Corporation or as otherwise
provided by law.
(b) The officers of Sub at the Effective Time shall be the initial
officers of the Surviving Corporation and shall hold office from the
Effective Time until their respective successors are duly elected or
appointed and qualify in the manner provided in the Articles of
Incorporation and by-laws of the Surviving Corporation, or as otherwise
provided by law.
ARTICLE III
CONVERSION OF SHARES
Section 3.1 Merger Consideration. At the Effective Time, by virtue of the
Merger and without any action on the part of the holder thereof:
(a) Each of the shares of the Company's Common Stock, par value $1.00
per share (the "Shares"), issued and outstanding immediately prior to the
Effective Time (other than Shares held in the treasury of Company or by
Parent or any subsidiary of Parent or Company) shall be converted into the
right to receive $14.55 in cash payable upon the surrender of the
certificate formerly representing such Share;
(b) Each Share held in the treasury of Company, if any, and each Share
held by Parent or any subsidiary of Parent or Company immediately prior to
the Effective Time shall be cancelled and retired and cease to exist; and
(c) Each share of Common Stock of Sub, par value $.01 per share,
issued and outstanding immediately prior to the Effective Time shall be
converted into and become a fully paid and nonassessable share of Common
Stock of the Surviving Corporation.
Section 3.2 Exchange of Consideration for Shares.
(a) Prior to the Effective Time, Parent shall deposit, or shall cause to be
deposited, with an exchange agent selected by Parent and reasonably satisfactory
to the Company (the "Exchange Agent"), for the benefit of the holders of Shares
and options to purchase shares ("Options"), for exchange in accordance with this
Article III, the following:
2
<PAGE>
(i) cash to be paid with respect to all Shares outstanding immediately prior to
the Effective Time and which are to be exchanged pursuant to the Merger
(exclusive of shares to be cancelled pursuant to Section 3.1(b)) and (ii) cash
which may be paid on the exercise of any Options outstanding immediately prior
to the Effective Time which have an exercise price of $14.54 or less, less, with
respect to each such Option, the exercise price thereof (such cash being
hereinafter referred to collectively as the "Exchange Fund").
(b) Promptly after the Effective Time, Parent shall cause the Exchange
Agent to mail (or deliver at its principal office) to each holder of record of a
certificate or certificates representing Shares (i) a letter of transmittal
which shall specify that delivery shall be effected, and risk of loss and title
to the certificates for Shares shall pass, only upon delivery of the
certificates for Shares to the Exchange Agent and shall be in such form and have
such other provisions, including appropriate provisions with respect to back-up
withholding, as Parent may reasonably specify, and (ii) instructions for use in
effecting the surrender of the certificates for Shares. Furthermore, promptly
after the Effective Time, Parent shall cause the Exchange Agent to mail (or
deliver at its principal office) to each holder of Options outstanding
immediately prior the Effective Time similar materials. Upon surrender of a
certificate for Shares for cancellation to the Exchange Agent, or upon notice of
issuance of the exercise of Options, accompanied by such letter of transmittal,
duly executed and completed in accordance with the instructions thereto, the
holder thereof shall be entitled to receive in exchange therefor that portion of
the Exchange Fund which such holder has the right to receive pursuant to the
provisions of this Article III, after giving effect to any required withholding
tax, and the certificate for Shares so surrendered shall forthwith be cancelled.
No interest will be paid or accrued on the Exchange Fund. In the event of any
transfer of ownership of Shares which has not been registered in the transfer
records of the Company, a check in an amount equal to the proper amount of
Exchange Fund allocated to such Shares will be issued to the transferee of the
certificate representing the transferred Shares presented to the Exchange Agent,
accompanied by all documents required to evidence and effect the prior transfer
thereof and to evidence that any applicable stock transfer taxes associated with
such transfer were paid.
Section 3.3 Closing of Company Transfer Books. At the Effective Time, the
stock transfer books of Company shall be closed, and no transfer of Shares shall
thereafter be made. If, after the Effective Time, certificates representing
Shares are presented to the Surviving Corporation, they shall be cancelled and
exchanged for the portion of the Exchange Fund allocated to such Shares.
Section 3.4 Closing. The consummation of the transactions contemplated by
this Agreement (the "Closing") shall take place at the offices of Christensen,
Miller, Fink, Jacobs, Glaser, Weil & Shapiro, LLP, 2121 Avenue of the Stars,
Suite 1800, Los Angeles, California, at 10:00 a.m., local time, on the first
business day after the day on which all of the conditions set forth in Article
VIII are satisfied or waived or at such other date, time and place as Parent and
Company shall agree.
3
<PAGE>
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PARENT
Except as otherwise disclosed to Company in a disclosure schedule
delivered to it concurrently with the execution hereof (which disclosure
schedule shall contain appropriate references to identify the representations
and warranties herein to which the information in such disclosure schedule
relates) (the "Parent Disclosure Schedule"), Parent represents and warrants to
Company as follows:
Section 4.1 Organization. Each of Parent and Sub is a corporation
duly organized, validly existing and in good standing under the laws of the
state of its incorporation and has the corporate power to carry on its business
as it is now being conducted or presently proposed to be conducted. Each of
Parent and Sub is duly qualified as a foreign corporation to do business, and is
in good standing, in each jurisdiction where the character of its properties
owned or held under lease or the nature of its activities make such
qualification necessary, except where the failure to be so qualified would not
have a material adverse effect on the business, assets, liabilities, results of
operations or financial condition of Parent and its subsidiaries, taken as a
whole (a "Parent Material Adverse Effect").
Section 4.2 Authority Relative to This Agreement. Each of Parent and
Sub has the requisite corporate power and authority to enter into this Agreement
and any other agreements executed in connection herewith (the "Transaction
Documents") and to carry out its obligations hereunder and thereunder and to
consummate the transactions contemplated hereby and thereby. The execution and
delivery of this Agreement and the other Transaction Documents to which Parent
and/or Sub is a party and the consummation by each of Parent and Sub of the
transactions contemplated hereby and thereby have been duly authorized by the
Board of Directors of each of Parent and Sub and by Parent as the sole
stockholder of Sub, and no other corporate action or proceedings on the part of
either Parent or Sub (including without limitation any action by Parent's
stockholders) are necessary to authorize the execution and delivery of this
Agreement and the other Transaction Documents or the consummation of the
transactions contemplated hereby and thereby. This Agreement and the other
Transaction Documents to which Parent and/or Sub is a party have been duly and
validly executed and delivered by Parent and Sub, as applicable, and constitute
valid and binding agreements of each of Parent and Sub, enforceable against each
of Parent and Sub in accordance with their terms, subject to bankruptcy,
insolvency, reorganization, moratorium or similar laws now or hereafter in
effect relating to creditors' rights generally or to general principles of
equity.
Section 4.3 Consents and Approvals; No Violations. Except for
applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended (the "HSR Act"), the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), state or foreign laws relating to takeovers, if
applicable, state securities or blue sky laws, certain state and local
regulatory filings and approvals relating to health care licensing and similar
matters, and the filing of appropriate Articles of Merger in such form as
required by, and
4
<PAGE>
executed in accordance with the relevant provisions of, the GCL, no filing with,
and no permit, authorization, consent or approval of, any public body or
authority is necessary for the consummation by Parent or Sub of the transactions
contemplated by the Transaction Documents, except for such filings, permits,
authorizations, consents or approvals the failure of which to be made or
obtained would not individually or in the aggregate have a Parent Material
Adverse Effect. Neither the execution and delivery by Parent or Sub of this
Agreement and the other Transaction Documents to which either of them is a
party, nor the consummation by Parent or Sub of the transactions contemplated
hereby and thereby, nor compliance by Parent or Sub with any of the provisions
hereof or thereof, will (a) conflict with or result in any breach of any
provisions of the charter documents or by-laws of Parent or Sub, (b) result in a
violation or breach of, or constitute (with or without due notice or lapse of
time or both) a default (or give rise to any right of termination, cancellation
or acceleration) under, any of the terms, conditions or provisions of any note
bond, mortgage, indenture, license, contract, agreement or other instrument or
obligation to which Parent or any of its subsidiaries is a party or by which any
of them or any of their properties or assets may be bound, or (c) violate any
order, writ, injunction, decree, statute, rule or regulation applicable to
Parent, any of its subsidiaries or any of their properties or assets, except in
the case of clauses (b) and (c) for violations, breaches or defaults which would
not have a Parent Material Adverse Effect.
Section 4.4 Financing for the Merger. With respect to the direct or
indirect financing for the Merger (either financing obtained by or on behalf of
Parent or any affiliate of Parent, including Sub), Parent agrees:
(a) That Parent will advise Company at such times and in such detail
as the Company may reasonably request as to the status of such financing
(Section 4.4 of the Parent Disclosure Schedule sets forth Parent's present
financing plans);
(b) That Parent and Sub are, and prior to and after giving effect to
the consummation of the Merger, Parent and the Surviving Corporation (as the
case may be) will be, solvent. For purposes of this Agreement, the term
"solvent" shall mean, with respect to an entity, that the fair valuation of its
property is, on the date of determination, greater than the total amount of its
liabilities as of such date and that the present fair saleable value of the
entity's assets is on a reasonably prompt sale, on the date of determination,
greater than the amount that will be required to pay the entity's probable
liability on its existing debts as they become absolute and matured. For the
purpose of the foregoing definition, all debts shall be considered, whether
matured or unmatured, liquidated or unliquidated, absolute, fixed or contingent.
After giving effect to the consummation of the Merger, Parent and the Surviving
Corporation (as the case may be) will not have unreasonably small capital with
which to conduct their respective businesses. Prior to and after giving effect
to the consummation of the Merger, Parent, Sub and the Surviving Corporation (as
the case may be) will incur debts only within their ability to pay as such debts
mature.
(c) That Parent will provide Company (and its Board of Directors) with
an opinion from an entity acceptable to the Board of Directors of Company (the
"Solvency
5
<PAGE>
Firm") which opinion shall be satisfactory in form and substance to the Board of
Directors in the exercise of its reasonable judgment. The Board of Directors of
Company shall have the right to interview representatives of the Solvency Firm
as to such opinion and the basis for such opinion, and such Board of Directors
shall have been satisfied in the exercise of its reasonable judgment with
respect thereto. The failure to provide such opinion or to satisfy reasonable
inquiries by the Board of Directors of Company (or its representatives) will be
deemed to be a material breach of this Agreement by Parent.
(d) That such financing will not (i) violate, conflict with, or result
in a breach of any provisions of, or constitute a default (or an event which,
with notice or lapse of time or both, would constitute a default) under, or
result in the termination of, or accelerate the performance required by, or
result in a right of termination or acceleration under, or result in the
creation of any lien, security interest, charge or encumbrance upon any of the
material properties or assets of Company or the Surviving Corporation under, any
of the terms, conditions or provisions of (x) its charter or by-laws or (y) any
material note, bond, mortgage, indenture, deed of trust, license, lease,
agreement or other instrument or obligation which is made available to Parent to
which Company (or any of its subsidiaries) is a party or to which any of them,
or any of their properties or assets, may be subject; or (ii) violate any
judgment, ruling, order, writ, injunction or decree which is made available to
Parent or any statute, rule or regulation applicable to Company or the Surviving
Corporation or to which any of its properties or assets may be subject.
4.5 Available Funds. Parent has obtained commitments from its
stockholders (the "Investors") in the form of Schedule 4.5 hereof (the
------------
"Stockholder Commitments") confirming their commitments to contribute to Parent
certain funds aggregating $ , which may be used to satisfy any all
amounts which may be necessary to pay the Merger consideration and/or to satisfy
any obligation as a result of Parent's breach of any representations, warranties
or agreements contained herein. Parent has delivered true and correct copies of
the Stockholder Commitments to Company.
Section 4.6 Information in Proxy Statement. None of the information
to be supplied by Parent for inclusion in the proxy statement or any amendments
or supplements thereto to be distributed in connection with Company's meeting of
stockholders to vote upon this Agreement (the "Proxy Statement") will, at the
time of the mailing of the Proxy Statement and any amendments or supplements
thereto and at the time of the meeting of stockholders to be held in connection
with the Merger, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they are
made, not misleading.
Section 4.7 Compliance with Health Care Regulations
(a) All hospitals and other health care facilities owned or operated
by Parent or any of its subsidiaries (each, a "Parent Facility") are in
substantial compliance with the requirements of the Medicare and Medicaid
programs and any other federally or state funded
6
<PAGE>
health care programs (each, a "Government Health Care Program") in which a
Parent Facility participates. Neither Parent nor any of its subsidiaries has
received notice from any governmental agency, fiscal intermediary, carrier or
similar entity which enforces or administers the statutory or regulatory
provisions in respect to a Government Health Care Program or from any other
regulatory authority of any pending or threatened investigations, the outcome of
which, in the reasonable judgment of Parent, is likely to have a Parent Material
Adverse Effect, and neither Parent nor its subsidiaries has any reason to
believe that any such investigations are pending, threatened or imminent.
(b) Each Parent Facility is properly licensed by the department of
health or applicable state agency to conduct its business in substantially the
manner conducted by such Parent Facility. The Parent Facilities are presently
in substantial compliance with all of the terms, conditions and provisions of
such licenses. The facilities, equipment, staffing and operations of the Parent
Facilities satisfy the applicable state health care licensing requirements in
all material respects.
(c) Parent has no reason to believe that it will not obtain the
consents referred to in Section 8.1(d) on or before November 30, 1997.
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF COMPANY
Except as otherwise disclosed to Parent and Sub in a disclosure schedule
delivered to them concurrently with the execution hereof (which disclosure
schedule shall contain appropriate references to identify the representations
and warranties herein to which the information in such letter relates) (the
"Company Disclosure Schedule"), Company represents and warrants to Parent and
Sub as set forth below. Notwithstanding anything contained herein to the
contrary, Company is not making any representations and warranties with respect
to Behavioral Healthcare Corporation ("BHC") or its operations.
Section 5.1 Organization. Company is a corporation duly organized,
validly existing and in good standing under the laws of the State of Nevada and
has the requisite corporate power to carry on its business as it is now being
conducted or presently proposed to be conducted. Company is duly qualified as a
foreign corporation to do business, and is in good standing, in each
jurisdiction where the character of its properties owned or held under lease or
the nature of its activities makes such qualification necessary, except where
the failure to be so qualified would not individually or in the aggregate have a
material adverse effect on the business, assets, liabilities, results of
operations or financial condition of Company and its subsidiaries, taken as a
whole (a "Company Material Adverse Effect").
Section 5.2 Capitalization. The authorized capital stock of Company
consists of 100,000,000 Shares and 2,000,000 shares of Preferred Stock, par
value $1.00 per share. As of March 31, 1997, (i) 38,828,931 Shares were issued
and outstanding (excluding treasury
7
<PAGE>
shares), (ii) Options to acquire 3,981,130 Shares were outstanding under all
stock option plans and employee-related agreements of Company, (iii) 178,518
Shares in connection with Company's 5 3/4% Convertible Subordinated Debentures
due 2012, (iv) no shares of Preferred Stock were outstanding, and (v) rights to
purchase 38,828,931 shares of Series B Junior Participating Preferred Stock were
outstanding (excluding rights attached to treasury shares). All of the issued
and outstanding Shares are validly issued, fully paid and nonassessable and free
of preemptive rights. There are not now, and at the Effective Time there will
not be, any shares of capital stock of Company issued or outstanding or any
options, warrants, subscriptions, calls, rights, convertible securities or other
agreements or commitments obligating Company to issue, transfer or sell any
shares of its capital stock except (i) as set forth above (including upon the
exercise of the Options and rights and conversion of the convertible debentures
referred to above) or (ii) as otherwise provided in this Agreement. There are no
outstanding obligations of Company or any Company Subsidiary to repurchase,
redeem or other acquire any securities of Company or such subsidiary.
Section 5.3 Subsidiaries. Each Company Subsidiary (as defined herein) is,
directly or indirectly, wholly owned by the Company. As used herein, "Company
Subsidiary" shall mean any corporation, partnership, joint venture or other
business entity (excluding any entities which are not material to the Company)
of which Company owns, directly or indirectly, greater than fifty percent of the
shares of capital stock or other equity interests (including partnership
interests) entitled (without regard to the occurrence of any contingency) to
cast at least a majority of the votes that may be cast by all shares or equity
interests having ordinary voting power for the election of directors or other
governing body of such entity.
(a) Each Company Subsidiary that is a corporation is a corporation duly
organized, validly existing and in good standing under the laws of the state of
its incorporation and each Company Subsidiary that is a partnership or a limited
liability company is duly formed and validly existing under the laws of the
state of its formation, in each case except where the failure to comply with the
foregoing would not constitute a Company Material Adverse Effect.
(b) Each Company Subsidiary has the requisite power to carry on its
business as it is now being conducted or presently proposed to be conducted,
except where the failure to have such power would not constitute a Company
Material Adverse Effect.
(c) Each Company Subsidiary that is a corporation is duly qualified as a
foreign corporation to do business, and is in good standing, in each
jurisdiction where the character of its properties owned or held under lease or
the nature of its activities makes such qualification necessary, except where
the failure to be so qualified would not have a Company Material Adverse Effect.
Each Company Subsidiary that is a partnership or limited liability company is
duly qualified as a foreign partnership or limited liability company authorized
to do business, and is in good standing, in each jurisdiction where the
character of its properties owned or held under lease or the nature of its
activities makes such
8
<PAGE>
qualification necessary, except where the failure to be so qualified would not
have a Company Material Adverse Effect.
(d) All of the outstanding shares of capital stock of the Company
Subsidiaries that are corporations are validly issued, fully paid and
nonassessable.
(e) There are no outstanding options, warrants, subscriptions, calls,
rights, convertible securities or other agreements or commitments obligating
Company or any Company Subsidiary to issue, transfer or sell any securities of
any Company Subsidiary.
(f) There are no voting trusts, standstill, stockholder or other agreements
or understandings to which Company or any of the Company Subsidiaries is a party
or is bound with respect to the voting of the capital stock of Company or any of
the Company Subsidiaries.
(g) All shares of common stock and preferred stock of BHC owned by Company
are owned free and clear of all claims, liens or encumbrances and the transfer
of control over such shares contemplated hereby will not violate any agreement
to which Company or any Company Subsidiary is a party.
Section 5.4 Authority Relative to This Agreement. Company has the
corporate power and authority to enter into this Agreement and the other
Transaction Documents to which it is a party and to carry out its obligations
hereunder and thereunder and to consummate the transactions contemplated hereby
and thereby. The execution and delivery by Company of this Agreement and each
of the other Transaction Documents to which it is a party and the consummation
by Company of the transactions contemplated hereby and thereby have been duly
authorized by Company's Board of Directors and, except for the approval of
Company's stockholders to be sought at the stockholders meeting contemplated by
Section 7.3(a) hereof, no other corporate action or proceedings on the part of
Company are necessary to authorize this Agreement or the transactions
contemplated hereby. This Agreement and the other Transaction Documents to
which Company is a party have been duly and validly executed and delivered by
Company and each constitutes a valid and binding agreement of Company,
enforceable against Company in accordance with its terms, subject to bankruptcy,
insolvency, reorganization, moratorium or similar laws now or hereafter in
effect relating to creditors' rights generally or to general principles of
equity.
Section 5.5 Consents and Approvals; No Violation. Except for applicable
requirements of the HSR Act, the Exchange Act, state securities or blue sky
laws, certain state and local regulatory filings and approvals relating to
health care licensing and similar matters, and the filing and recordation of the
Articles of Merger as required by the GCL, no filing with, and no permit,
authorization, consent or approval of, any public body or authority is necessary
for the consummation by Company of the transactions contemplated by the
Transaction Documents, except for such filings, permits, authorizations,
consents or approvals the failure of which to be made or obtained would not
individually or in the aggregate have a Company Material Adverse Effect. Neither
the execution and delivery by
9
<PAGE>
Company of this Agreement and the other Transaction Documents to which it is a
party, nor the consummation by Company of the transactions contemplated hereby
and thereby, nor compliance by Company with any of the provisions hereof and
thereof, will (i) conflict with or result in any breach of any provisions of the
charter documents or by-laws of Company or any of the Company Subsidiaries, (ii)
result in a violation or breach of, or constitute (with or without due notice or
lapse of time or both) a default (or give rise to any right of termination,
cancellation or acceleration) under, any of the terms, conditions or provisions
of any note, bond, mortgage, indenture, license, contract, agreement or other
instrument or obligation to which Company or any of the Company Subsidiaries is
a party or by which any of them or any of their properties or assets may be
bound, or (iii) assuming compliance with the matters referred to in this Section
5.5, violate any order, writ, injunction, decree, statute, rule or regulation
applicable to Company, any of the Company Subsidiaries or any of their
properties or assets, except in the case of clauses (ii) and (iii) for
violations, breaches or defaults which would not have a Company Material Adverse
Effect.
Section 5.6 Reports and Financial Statements. Company has timely filed
all reports required to be filed with the Securities and Exchange Commission
("SEC") pursuant to the Exchange Act since December 1, 1993 (collectively, the
"Company SEC Reports"). None of such Company SEC Reports, as of their respective
dates, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Each of the balance sheets (including the related notes) included in
the Company SEC Reports fairly presents the consolidated financial position of
Company and the Company Subsidiaries as of the respective dates thereof, and the
other related statements (including the related notes) included therein fairly
present the results of operations and the changes in financial position of
Company and the Company Subsidiaries for the respective periods or as of the
respective dates set forth therein (subject, in the case of unaudited
statements, to normal year-end audit adjustments), all in conformity with
generally accepted accounting principles ("GAAP") consistently applied during
the periods involved, except as otherwise noted therein.
Section 5.7 Absence of Undisclosed Liabilities. Except for liabilities or
obligations which (i) are accrued or reserved against in Company's financial
statements (or reflected in the notes thereto) included in the Company SEC
Reports, or (ii) were incurred after February 28, 1997 in the ordinary course of
business and consistent with past practices, neither Company nor any Company
Subsidiary has any material liabilities or obligations (whether absolute,
accrued, contingent or otherwise) of a nature required by GAAP to be reflected
in a corporate balance sheet or the notes thereto.
Section 5.8 Absence of Certain Changes or Events. Except as set forth in
the Company SEC Reports, since February 28, 1997 neither Company nor any of the
Company Subsidiaries has: (i) taken any of the actions set forth in Sections
6.1(b), 6.1(c) or 6.1(e) hereof; (ii) suffered any material adverse change in
the business, financial condition, results of operations, properties, assets or
liabilities of Company and the Company Subsidiaries taken as a whole (other than
any change relating to the United States economy in general or
10
<PAGE>
to the United States investor owned hospital business or to the long-term acute
care hospital business in general); or (iii) subsequent to the date hereof,
except as permitted by Section 6.1 hereof, conducted its business and operations
other than in the ordinary course of business and consistent with past
practices.
Section 5.9 Litigation. Except for litigation disclosed in the notes to
the financial statements included in the Company SEC Reports, there is no suit,
action or proceeding pending or, to the best of Company's knowledge, threatened
against or affecting Company or any of the Company Subsidiaries, the outcome of
which, in the reasonable judgment of Company, is likely to have a Company
Material Adverse Effect; nor is there any judgment, decree, injunction,
citation, settlement agreement, rule or order of any court, governmental
department, commission, agency, instrumentality or arbitrator outstanding
against Company or any of the Company Subsidiaries having, or which, insofar as
can reasonably be foreseen by Company, in the future may have, any such effect.
Section 5.10 Information in Proxy Statement. None of the information to
be supplied by Company for inclusion or incorporation by reference in the Proxy
Statement will, at the time of the mailing of the Proxy Statement and any
amendments or supplements thereto and at the time of the meeting of stockholders
to be held in connection with the Merger, contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading. The Proxy Statement
will comply as to form in all material respects with the provisions of the
Exchange Act and the rules and regulations promulgated thereunder.
Section 5.11 No Default. Neither Company nor any of the Company
Subsidiaries is in default or violation (and no event has occurred which with
notice or the lapse of time or both would constitute a default or violation) of
any term, condition or provision of (i) its charter documents or by-laws, (ii)
any note, bond, mortgage, indenture, license, agreement, contract, lease,
commitment or other obligation to which Company or any of the Company
Subsidiaries is a party or by which they or any of their properties or assets
may be bound, or (iii) any order, writ, injunction, decree, statute, rule or
regulation applicable to Company or any of the Company Subsidiaries, except in
the case of clauses (ii) and (iii) above for defaults or violations which would
not have a Company Material Adverse Effect.
Section 5.12 Taxes.
(a) Except for such matters that would not be reasonably likely to have,
individually or in the aggregate, a Company Material Adverse Effect, Company and
the Company Subsidiaries have duly filed all material Tax Returns required to be
filed by Company or the Company Subsidiaries and have paid the Taxes shown to be
due thereon. The most recent financial statements contained in the Company SEC
Reports adequately provide for the payment of taxes for the periods covered by
such Company SEC Reports. No material deficiencies for Taxes have been assessed
or asserted by a "30-Day Letter" or a notice of deficiency as defined in Section
6212 of the Internal Revenue Code of 1986, as
11
<PAGE>
amended (the "Code"), or similar notice under state, local, or foreign law,
which would have a Company Material Adverse Effect or for which adequate
reserves have not been established in the most recent financial statements
contained in the most recent Company SEC Reports as of the date hereof.
(b) For purposes of this Agreement:
(i) "Taxes" shall mean all Federal, state, local and foreign taxes,
and other assessments of a similar nature (whether imposed directly or
through withholding), including any interest, additions to tax, or
penalties applicable thereto.
(ii) "Tax Returns" shall mean all Federal, state, local and foreign
tax returns, declarations, statements, reports, schedules, forms and
information returns and any amended Tax Return relating to Taxes.
Section 5.13 Medicare Participation/Accreditation.
(a) All hospitals or significant health care facilities owned or operated
as continuing operations by Company or any Company Subsidiary (each, a "Company
Facility") are certified for participation in the Medicare and Medicaid
programs, have a current and valid provider agreement with the Medicare and
Medicaid programs, and are in substantial compliance with the conditions of
participation of such programs, except where the failure to be so certified, to
have such agreements, or to be in such compliance would not have a Company
Material Adverse Effect. Neither Company nor any of the Company Subsidiaries
has received notice from any governmental agency, fiscal intermediary, carrier
or similar entity which enforces or administers the statutory or regulatory
provisions in respect to any Government Health Care Program of any pending or
threatened investigations, and to Company's knowledge, no such investigations
are pending, threatened or imminent, which are reasonably expected by Company to
have a Company Material Adverse Effect. Each Company Facility eligible for such
accreditation is accredited by the Joint Commission on Accreditation of
Healthcare Organizations or other appropriate accreditation agency. All
returns, cost reports and other filings made by Company and the Company
Subsidiaries with Medicare, Medicaid or any other governmental health care
program or third party payor are complete and accurate except where the failure
to be so complete and accurate would not have, individually or in the aggregate,
a Company Material Adverse Effect. No adjustment or disallowance in any such
cost reports and other requests for payment, including adjustments or
disallowances for late filings, has been made or, to the best knowledge of
senior management of Company, threatened by any Federal or state agency or
instrumentality or other provider reimbursement entities relating to Medicare or
Medicaid or by any third party payor which individually or in the aggregate
would have a Company Material Adverse Effect, and, to the best knowledge of
Company, there is no basis for any successful claims or requests for recovery of
overpayments from any such agency, instrumentality, entity or third party payor
except for any such claims or requests which would not have, individually or in
the aggregate, a Company Material Adverse Effect.
12
<PAGE>
(b) Each such Company Facility is licensed by the state department of
health or applicable state agency to conduct its business in substantially the
manner conducted by such Company Facility and is authorized to operate the
number of beds utilized therein, except for failures to be licensed or lack of
authorizations that will not have a Company Material Adverse Effect. The
Company Facilities are presently in substantial compliance with the material
terms, conditions and provisions of such licenses except where the failure to be
in such compliance would not result in a Company Material Adverse Effect. The
facilities, equipment, staffing and operations of the Company Facilities satisfy
the applicable state health care licensing requirements in all material
respects, except for failures which would not result in a Company Material
Adverse Effect.
Section 5.14 Employee Benefit Plans; ERISA.
(a) With respect to each material bonus, deferred compensation, incentive
compensation, stock purchase, stock option, severance or termination pay,
hospitalization or other medical, life or other insurance, supplemental
unemployment benefits, profit-sharing, pension, or retirement plan, program,
agreement or arrangement, and each other employee benefit plan, program,
agreement (including but not limited to employment agreements) or arrangement
(the "Plans"), currently maintained or contributed to or required to be
contributed to by (i) Company, (ii) any Company Subsidiary or (iii) any trade or
business, whether or not incorporated (a "Company ERISA Affiliate"), that
together with Company is a "single employer" within the meaning of Section 4001
of the Employee Retirement Income Security Act of 1974, as amended, and the
rules and regulations promulgated thereunder ("ERISA"), for the benefit of any
employee or former employee of Company, any Company Subsidiary or any Company
ERISA Affiliate, Company has heretofore delivered or will after the date hereof
make available to Parent, upon request, true and complete copies of each of the
following documents:
(i) a copy of each Plan that is in writing (including all amendments
thereto);
(ii) a copy of the annual report and actuarial report, if required
under ERISA, with respect to each such Plan for the last two plan years
ending prior to the date hereof;
(iii) a copy of the most recent Summary Plan Description, together
with each Summary of Material Modifications, if required under ERISA, with
respect to such Plan;
(iv) if the Plan is funded through a trust or any other third party
funding vehicle, a copy of the trust or other funding agreement (including
all amendments thereto) and the latest financial statements with respect to
the last reporting period ended immediately prior to the date hereof; and
13
<PAGE>
(v) the most recent determination letter received prior to the date
hereof from the Internal Revenue Service with respect to each Plan intended
to qualify under Section 401 of the Code.
(b) No liability under Title IV of ERISA has been incurred by Company, any
Company Subsidiary or any Company ERISA Affiliate that has not been satisfied in
full when due. The Company has no reason to expect to incur any liability under
ERISA arising in connection with the termination of, or complete withdrawal
from, any Plan previously covered by Title IV of ERISA which would have a
Company Material Adverse Effect or give rise to a lien under Title IV of ERISA.
(c) No Plan subject to the minimum funding requirements of Section 412 of
the Code or Section 302 of ERISA or any trust established thereunder has
incurred any "accumulated funding deficiency" (as defined in Section 302 of
ERISA and Section 412 of the Code), whether or not waived, as of the last day of
the most recent fiscal year of such Plan ended prior to the date hereof; and all
contributions required to be made with respect thereto (whether pursuant to the
terms of any such Plan or otherwise) on or prior to the date hereof have been
timely made.
(d) No Plan is a "multiemployer pension plan," as defined in Section 3(37)
of ERISA, nor is any Plan a plan described in Section 4063(a) of ERISA.
(e) Each Plan intended to be "qualified" within the meaning of Section
401(a) of the Code has received a favorable determination letter from the
Internal Revenue Service as to its qualification and, to Company's knowledge, no
amendment has been made to any such Plan since the date of such letter that is
likely to result in the disqualification of such Plan.
(f) Each of the Plans has been operated and administered in all respects in
accordance with applicable laws, including, but not limited to, ERISA and the
Code, except for any failure to so operate or administer such Plans that would
not have a material adverse effect on any such Plan.
(g) No Plan, individually or collectively, constitutes a "defined benefit
plan" as defined in Section 3(35) of ERISA.
(h) Neither Company nor any Company Subsidiary or, to the Company's
knowledge, any Company ERISA Affiliate, any of the ERISA Plans, any trust
created thereunder, or any trustee or administrator thereof has engaged in a
transaction in connection with which Company or any Company Subsidiary or, to
Company's knowledge, any Company ERISA Affiliate, any of the ERISA Plans, any
such trust or any trustee or administrator thereof, or any party dealing with
the ERISA Plans or any such trust is subject to either a civil liability under
Section 409 of ERISA or Section 502(i) of ERISA, or a tax imposed pursuant to
Section 4975 or 4976 of the Code other than any such liability or tax that would
not have a Company Material Adverse Effect.
14
<PAGE>
Section 5.15 Vote Required. Approval of the Merger by the stockholders of
Company will require the affirmative vote of the holders of two-thirds of the
outstanding Shares at the stockholders' meeting referred to in Section 7.3(a).
Section 5.16 Opinion of Financial Advisors. The Board of Directors of
Company has received the opinion of Dean Witter Reynolds, Inc. and Morgan
Stanley & Co., Company's financial advisors, substantially to the effect that
the consideration to be received by holders of the Shares is fair from a
financial point of view.
Section 5.17 Certain Actions Under Nevada Law. The Board of Directors of
the Company has taken all appropriate action so that (i) neither Parent nor Sub
will be an "interested stockholder" within the meaning of Sections 78.378 to
78.3793 of the GCL by virtue of the execution of this Agreement or the other
Transaction Documents and (ii) the entry into this Agreement and the
consummation of the transactions contemplated hereunder and under the other
Transaction Documents shall be exempted from the provisions of Sections 78.411
to 78.444 of the GCL.
Section 5.18 Shareholder Rights Plan. The Company has taken all necessary
actions to cause the dilution provisions of that certain Rights Agreement dated
as of June 21, 1996 between Company and Chase Mellon Shareholder Services,
L.L.C. to be inapplicable to the transactions contemplated by this Agreement and
the other Transaction Documents.
ARTICLE VI
CONDUCT OF BUSINESS PENDING THE MERGER
Section 6.1 Conduct of Business by Company Pending The Merger. From the
date of this Agreement to the Effective Time, unless Parent shall otherwise
agree in writing, or as otherwise contemplated by this Agreement, any Schedule
hereto or the Company Disclosure Schedule:
(a) the respective businesses of Company and the Company Subsidiaries shall
be conducted only in the ordinary and usual course of business and consistent
with past practices, and there shall be no material changes in the conduct of
the operations of Company and the Company Subsidiaries taken as a whole;
(b) Company shall not (i) sell or pledge or agree to sell or pledge any
stock owned by it in any of the Company Subsidiaries; (ii) amend its Articles of
Incorporation or by-laws; or (iii) split, combine or reclassify any shares of
its outstanding capital stock or declare, set aside or pay any dividend or other
distribution payable in cash, stock or property, or redeem or otherwise acquire
any shares of its capital stock or shares of the capital stock or other
securities of or ownership interests in any of the Company Subsidiaries;
15
<PAGE>
(c) neither Company nor any of the Company Subsidiaries shall (i) authorize
for issuance, issue or sell any additional shares of, or rights of any kind to
acquire any shares of, its capital stock of any class (whether through the
issuance or granting of options, warrants, commitments, subscriptions, rights to
purchase or otherwise), except for unissued Shares reserved for issuance upon
the exercise or conversion of outstanding rights, options and debentures
referred to in Section 5.2 hereof; (ii) acquire, dispose of, transfer, lease,
license, mortgage, pledge or encumber any fixed or other assets in excess of
$5,000,000 in any one or a series of related transactions other than in the
ordinary course of business and consistent with past practices; (iii) incur,
assume or prepay any indebtedness or any other material liabilities or create or
assume any lien on any material asset other than in the ordinary course of
business and consistent with past practices; (iv) assume, guarantee, endorse or
otherwise become liable or responsible (whether directly, contingently or
otherwise) for the obligations of any other person in an amount in excess of
$2,000,000 other than a Company Subsidiary in the ordinary course of business
and consistent with past practices; (v) make any loans, advances or capital
contributions to, or investments in, any other person in an amount in excess of
$2,000,000 other than to Company Subsidiaries and other than in the ordinary
course of business and consistent with past practices; (vi) authorize capital
expenditures substantially in excess of the amount currently budgeted therefor;
(vii) make any change in any method of accounting or accounting practice by
Company or any Company Subsidiary, except for any such change required by reason
of a concurrent change in GAAP; or (viii) enter into any contract, agreement,
commitment or arrangement with respect to any of the foregoing;
(d) Company shall use reasonable efforts to preserve intact the business
organization of Company and the Company Subsidiaries, to keep available the
services of its and their present officers and key employees, and to preserve
the goodwill of those having business relationships with it and the Company
Subsidiaries; and
(e) neither Company nor any of the Company Subsidiaries shall make any
change in the compensation payable or to become payable to any of its officers,
directors or employees, enter into or amend any employment, severance,
termination or other similar agreement, adopt any new Plan or amend in any
material respect any existing Plan (except that Company and Company Subsidiaries
may amend any Plan to provide for the effectuation thereof simultaneously with
the Effective Time), or make any loans to any of its officers, directors or
employees or make any changes in its existing borrowing or lending arrangements
for or on behalf of any of such persons, whether contingent on consummation of
the Merger or otherwise, other than (i) in the ordinary course of business and
consistent with past practice, and (ii) as may be required under applicable law
or the terms of any existing Plan or agreement.
Section 6.2 Conduct of Business by Parent Pending The Merger. From the
date of this Agreement to the Effective Time, unless Company shall otherwise
agree in writing, or as otherwise contemplated by this Agreement or the Parent
Disclosure Letter, the respective businesses of Parent and the Parent
Subsidiaries shall be conducted only in the ordinary and
16
<PAGE>
usual course of business and consistent with past practices, and there shall be
no material changes in the conduct of the operations of Parent or any Parent
Subsidiary.
Section 6.3 Conduct of Business of Sub. From the date hereof to the
Effective Time, Sub shall not engage in any activities of any nature except as
provided in or contemplated by this Agreement.
ARTICLE VII
ADDITIONAL AGREEMENTS
Section 7.1 Access and Information. Company shall afford to Parent and
its financial advisors, legal counsel, accountants, consultants and other
representatives full access at all reasonable times throughout the period prior
to the Effective Time to all of its books, records, properties, plants and
personnel and, during such period, shall furnish promptly to Parent (i) a copy
of each report, schedule and other document filed or received by it pursuant to
the requirements of federal or state securities laws and (ii) all other
information as Parent may reasonably request. Parent and its respective
affiliates, representatives and agents shall keep confidential all nonpublic
information in accordance with the terms of the Confidentiality Letter dated
April , 1997 (the "Confidentiality Letter") between Company and Parent. If
this Agreement is terminated, Parent will deliver to Company all documents, work
papers and other materials (including copies) obtained by Parent or on its
behalf from Company as a result of this Agreement or in connection herewith,
whether so obtained before or after the execution hereof.
Section 7.2 Acquisition Proposals. From the date hereof until the
termination hereof, the Company and the Company Subsidiaries will not, and will
cause their respective officers, directors, employees or other agents
(including, without limitation, investment bankers, attorneys or accountants)
not to, directly or indirectly, (i) take any action to solicit, initiate,
encourage, enter into any agreement or otherwise facilitate any offer or
proposal for, or any indication of interest in, a merger or other business
combination involving Company or the acquisition of any equity interest in, or a
substantial portion of the assets of Company, other than the transactions
contemplated by the Transaction Documents and other than the sale of the
hospital in Kirkland, Washington and the sale of real estate and buildings
relating to hospitals formerly operated by Company or a Company Subsidiary (an
"Acquisition Proposal"), or (ii) engage in or continue discussions or
negotiations with, or disclose any nonpublic information relating to Company or
the Company Subsidiaries, respectively, or afford access to their respective
properties, books or records to, any person that may be considering making, or
has made, an Acquisition Proposal, or otherwise facilitate any effort or attempt
to make or implement an Acquisition Proposal. Notwithstanding the foregoing,
nothing contained in this Section 7.2 shall prohibit Company and its Board of
Directors from (i) taking and disclosing a position with respect to a tender
offer by a third party pursuant to Rules 14d-9 and 14e-2(a) promulgated by the
SEC under the Exchange Act, or (ii) furnishing information to, or entering into
negotiations with, any person or entity that makes an unsolicited bona fide
proposal to acquire Company pursuant to a merger, consolidation, share
17
<PAGE>
exchange, purchase of a substantial portion of the assets, business combination
or other similar transaction, if, and only to the extent that, (i) such Board of
Directors determines in good faith upon advice of counsel that such action is
required for the Board of Directors to comply with its fiduciary duties to
stockholders imposed by law, and (ii) prior to furnishing such information to,
or entering into discussions or negotiations with, such person or entity,
Company provides written notice to Parent to the effect that it is furnishing
information to, or entering into discussions or negotiations with, such person
or entity, and Company keeps Parent informed of the status and principal
financial terms of any such negotiations or discussions.
Section 7.3 Proxy Statement; Stockholder Approval.
(a) Company, acting through its Board of Directors, shall, in accordance
with applicable law and its Articles of Incorporation and By-Laws:
(i) promptly and duly call, give notice of, convene and hold as soon
as practicable following the date upon which the Proxy Statement is cleared
for mailing by the SEC, a meeting of its stockholders for the purpose of
voting to approve and adopt this Agreement and shall use its reasonable
efforts to obtain such stockholder approval; and
(ii) recommend approval and adoption of this Agreement by the
stockholders of Company and include in the Proxy Statement such
recommendation, and take all lawful action to solicit such approval.
(b) Company, as promptly as practicable following the date upon which the
Proxy Statement is cleared for mailing by the SEC, shall cause the definitive
Proxy Statement to be mailed to its stockholders. At the stockholders' meeting,
Company shall vote or cause to be voted in favor of approval and adoption of
this Agreement all Shares as to which it holds proxies at such time.
(c) Company's obligations under this Section 7.3 shall at all times remain
subject to its fiduciary duties imposed under applicable law, in the event that,
if required by such fiduciary duties as advised by counsel, the Board of
Directors of Company shall have withdrawn or modified its recommendation that
stockholders approve and adopt this Agreement.
Section 7.4 Antitrust Laws. As promptly as practicable, Company, Parent
and Sub shall make all filings and submissions under the HSR Act as may be
reasonably required to be made in connection with this Agreement and the
transactions contemplated hereby. Company will furnish to Parent and Sub, and
Parent and Sub will furnish to Company, such information and assistance as the
other may reasonably request in connection with the preparation of any such
filings or submissions. Company will provide Parent and Sub, and Parent and Sub
will provide Company, with copies of all correspondence, filings or
communications (or memoranda setting forth the substance thereof) between such
party or
18
<PAGE>
any of its representatives, on the one hand, and any governmental agency or
authority or members of their respective staffs, on the other hand, with respect
to this Agreement and the transactions contemplated hereby.
Section 7.5 Employee Stock Options. At the Effective Time all outstanding
Options shall immediately vest and become fully exercisable. At the Effective
Time each Option with an exercise price of $14.54 or less (a "Lower Priced
Option") shall be amended to provide that the holders need not tender any
exercise price therefor and that upon exercise the holder shall receive an
amount of cash equal to $14.55 minus the exercise price of the Lower Priced
Option. All other Options shall be converted into a right to receive upon
exercise of such Options $14.55 in cash; anything to the contrary in this
Agreement notwithstanding, to the extent required by any applicable federal,
state or local law, the recipient of any payment pursuant to this Section 7.5
shall make arrangements satisfactory to the Company for the satisfaction of any
withholding tax obligations that arise by reason of such payment or
distribution. The Company shall not be required to make any such payment or
distribution until such obligations are satisfied. Anything to the contrary in
this Agreement notwithstanding, no payment shall be made pursuant to this
Section 7.5 that would be inconsistent with and would violate Article 12 of the
Company 1989 Stock Incentive Plan.
Section 7.6 Public Announcements. Parent and Sub, on the one hand, and
Company, on the other hand, agree that they will not issue any press release or
otherwise make any public statement or respond to any press inquiry with respect
to this Agreement or the transactions contemplated hereby without the prior
approval (which shall not be unreasonably withheld) of the other party, except
as may be required by law.
Section 7.7 Continuance of Existing Indemnification Rights.
(a) For a period of ten years from and after the Effective Time, Parent and
Surviving Corporation shall indemnify, and advance expenses in matters that may
be subject to indemnification to, persons who served as directors, officers,
employees or agents of Company or any entity in which Parent directly or
indirectly held equity securities on or before the Effective Time with respect
to liabilities and claims (and related expenses) made against them resulting
from their service as such prior to the Effective Time with and subject to the
requirements and other provisions of Company's Articles of Incorporation, by-
laws and indemnification agreements in effect on the date of this Agreement and
applicable provisions of Law.
(b) Parent shall cause to be maintained in effect for a period ending not
sooner than the sixth anniversary of the Effective Time directors' and officers'
liability insurance providing at least the same coverage with respect to
Company's directors and officers as the policies maintained on behalf of
directors and officers of Company as of the date hereof, and containing terms
and conditions which are no less advantageous, with respect to matters occurring
on or prior to the Effective Time (to the extent such insurance is available
with respect to such matters); provided, that in no event shall Parent be
required to expend to maintain or procure insurance coverage pursuant to this
Section 7.7 an amount per annum in
19
<PAGE>
excess of 200% of the current annual premiums (the "Maximum Premium") with
respect to such insurance, or, if the cost of such coverage exceeds the Maximum
Premium, the maximum amount of coverage that can be purchased or maintained for
the Maximum Premium.
(c) Parent shall reimburse all expenses, including attorneys' fees,
incurred by any person to enforce the obligations of Parent under this Section
7.7.
Section 7.8 Expenses. Except as set forth in this Section 7.8, whether or
not the Merger is consummated all costs and expenses incurred in connection with
this Agreement and the transactions contemplated hereby and thereby shall be
paid by the party incurring such expenses except that those expenses incurred in
connection with printing the Proxy Statement as well as the filing fee relating
to the Proxy Statement will be shared equally by Parent and Company.
Section 7.9 Additional Agreements. Subject to the terms and conditions
herein provided, each of the parties hereto agrees to use all reasonable efforts
to take, or cause to be taken, all action and to do, or cause to be done, all
things necessary, proper or advisable under applicable laws and regulations to
consummate and make effective the transactions contemplated by this Agreement,
including using all reasonable efforts to obtain all necessary waivers, consents
and approvals and to effect all necessary registrations and filings. In case at
any time after the Effective Time any further action is necessary or desirable
to carry out the purposes of this Agreement, the proper officers and/or
directors of Parent, Sub and Company shall take all such necessary action.
Section 7.10 Certain Employee Benefits. Parent and the Company agree to
take the actions described in Schedule 7.10 hereto.
-------------
Section 7.11 Cancellation of Converging Options. Prior to the Effective
Time Company shall cancel the converging options issued under the Company 1989
Stock Incentive Plan.
Section 7.12 Stockholder Commitments. Upon Company's request, Parent will
draw down the funds available under the Stockholder Commitments to satisfy
Parent's funding and other obligations under the Merger Agreement, including
without limitation, any obligations under Section 9.2(f) hereof.
ARTICLE VIII
CONDITIONS TO CONSUMMATION OF THE MERGER
Section 8.1 Conditions to Each Party's Obligation to Effect The Merger.
The respective obligations of each party to effect the Merger shall be subject
to the satisfaction at or prior to the Effective Time of the following
conditions:
20
<PAGE>
(a) Any waiting period applicable to the consummation of the Merger under
the HSR Act shall have expired or been terminated, and no action shall have been
instituted by the Department of Justice or Federal Trade Commission challenging
or seeking to enjoin the consummation of this transaction, which action shall
have not been withdrawn or terminated.
(b) This Agreement and the transactions contemplated hereby shall have been
approved and adopted by the requisite vote of the stockholders of Company in
accordance with applicable law.
(c) No preliminary or permanent injunction or other order by any federal or
state court in the United States which prohibits the consummation of the Merger
shall have been issued and remain in effect.
(d) Each of Company and Parent shall have obtained such consents from
government instrumentalities in addition to pursuant to the HSR Act as shall be
required and which are material to Parent and Company and to consummation of the
transactions contemplated hereby.
Section 8.2 Conditions to Obligation of Company to Effect The Merger. The
obligation of Company to effect the Merger shall be subject to the satisfaction
at or prior to the Effective Time of the following additional condition:
(a) Each of Parent and Sub shall have performed in all material respects
its obligations under this Agreement required to be performed by it at or prior
to the Effective Time and the representations and warranties of Parent and Sub
contained in this Agreement shall be true and correct in all material respects
at and as of the Effective Time as if made at and as of such time, except that
the representation and warranty contained in Section 4.7 need not be so correct
if the condition contained in Section 8.1 has been satisfied and except as
contemplated by this Agreement, and Company shall have received a certificate of
the Chairman of the Board, the Chief Executive Officer, the President or an
Executive Vice President of Parent as to the satisfaction of this condition.
(b) Company shall have received the opinion referred to in Section 4.4(c)
hereof.
Section 8.3 Conditions to Obligations of Parent and Sub to Effect The
Merger. The obligations of Parent and Sub to effect the Merger shall be subject
to the satisfaction at or prior to the Effective Time of the following
additional condition:
(a) Company shall have performed in all material respects its obligations
under this Agreement required to be performed by it at or prior to the Effective
Time and the representations and warranties of Company contained in this
Agreement shall be true and correct in all material respects at and as of the
Effective Time as if made at and as of such time, except as contemplated by this
Agreement, and Parent and Sub shall have received a
21
<PAGE>
Certificate of the Chairman of the Board, the Chief Operating Officer, or an
Executive Vice President of Company as to the satisfaction of this condition.
ARTICLE IX
TERMINATION, AMENDMENT AND WAIVER
Section 9.1 Termination. This Agreement may be terminated at any time
before the Effective Time, either before or after the approval of the
stockholders of Company shall have been obtained, in each case as authorized by
the respective Board of Directors of Parent or Company:
(a) By mutual written consent of the parties;
(b) By either Parent or Company if the Merger shall not have been
consummated on or before November 30, 1997 (the "Termination Date"); provided,
however, that the right to terminate this Agreement under this Section 9.1(b)
shall not be available to any party whose failure to fulfill any obligation
under this Agreement has been the cause of, or resulted in, the failure of the
Effective Time to occur on or before the Termination Date.
(c) By either Parent or Company if a court of competent jurisdiction or
governmental, regulatory or administrative agency or commission shall have
issued an order, decree or ruling or taken any other action (which order, decree
or ruling the parties shall use their commercially reasonable efforts to lift),
in each case permanently restraining, enjoining or otherwise prohibiting the
transactions contemplated by this Agreement, and such order, decree, ruling or
other action shall have become final and nonappealable;
(d) By Parent if Company shall be in material breach of its obligations
under this Agreement and such breach has not been cured within 30 days' written
notice thereof to the Company; or by Company (i) if Parent or Sub shall be in
material breach of their respective obligations under this Agreement and such
breach has not been cured within 30 days' notice thereof to Parent, or (ii) any
of the Investors shall be in material breach of its obligations under the
Stockholder Commitments and such breach has not been cured within 30 days'
notice thereof to Parent.
(e) By Parent if the Board of Directors of Company (i) shall withdraw or
modify (or publicly announce an intention to withdraw or modify) in any adverse
manner its approval or recommendation of this Agreement or the Merger, (ii)
shall approve or recommend any Acquisition Proposal, other than by a party or an
affiliate thereof, or (iii) shall resolve to take any of the actions specified
in clause (i) or (ii) above;
(f) By either Parent or Company if the required approval of the
stockholders of Company shall fail to have been obtained at a duly held
stockholders meeting of Company, including any adjournments thereof;
22
<PAGE>
(g) By Company upon five days' prior written notice to Parent, if, as a
result of an Acquisition Proposal (as defined in Section 7.2 hereof) received by
Company from a person other than Parent or any of its affiliates, the Board of
Directors of Company determines in good faith that the members' fiduciary
obligations under applicable law require that such Acquisition Proposal be
accepted; provided, however, that (i) the Board of Directors of Company shall
have determined in good faith, after considering applicable provisions of state
law and after giving effect to all concessions, if any, which have been offered
by Parent pursuant to clause (ii) below, on the basis of oral or written advice
of outside counsel, that such action is required by the members' fiduciary
obligations under applicable law, and (ii) prior to any such termination,
Company shall, and shall cause its respective financial and legal advisors to,
negotiate with Parent to make such adjustments in the terms and conditions of
this Agreement as would enable such party to proceed with the transactions
contemplated hereby; provided, however, that no termination shall be effective
pursuant to Sections 9.1(e) or (g) under circumstances in which a Company
Termination Fee (as defined below) is payable by the terminating party under
Section 9.2(b) unless concurrently with such termination such termination fee is
paid in accordance with the provisions of Sections 9.2(b); or
(h) By Parent if the Board of Directors of Company shall have failed to
take any of the actions contemplated by Section 7.3(a) as a result of the
exercise of its rights under Section 7.3(c).
Section 9.2 Effect of Termination.
(a) In the event of termination of this Agreement as provided in Section
9.1 hereof, and except as otherwise provided in this Agreement, this Agreement
shall forthwith become void and there shall be no liability on the part of any
of the parties, except (i) as set forth in this Section 9.2 and in Sections 7.1
and 7.8 and (ii) nothing herein shall relieve any party from liability for any
breach hereof.
(b) If this Agreement is terminated (i) by Parent pursuant to Section
9.1(e) hereof, (ii) by Parent as a result of Company's material breach of
Section 7.2 hereof, (iii) by Parent pursuant to Section 9.1(h) hereof, (iv) by
Parent pursuant to Section 9.1(d) hereof or (v) by Parent pursuant to Section
9.1(g) hereof or in the event Company shall consummate an Acquisition Proposal
on terms more favorable than the Merger, which Proposal was first made to
Company prior to its stockholders meeting to consider this Agreement, Company
shall pay to Parent a termination fee of $19,415,000 (the "Company Termination
Fee").
(c) The termination fee payable under Section 9.2(b) shall be payable in
cash.
(d) Parent and Company agree that the agreements contained in Section
9.2(b) above are an integral part of the transactions contemplated by this
Agreement and constitute liquidated damages and not a penalty. If Company fails
to promptly pay any fee due under such Section 9.2(b), Company shall pay the
costs and expenses (including legal fees and expenses) in connection with any
action, including the filing of any lawsuit or other legal
23
<PAGE>
action, taken to collect payment, together with interest on the amount of any
unpaid fee at the publicly announced reference rate of Bank of America N.T. &
S.A. from the date such fee was required to be paid.
(e) As used herein, "Alternative Transaction" means any of (i) a
transaction or series of transactions pursuant to which any person (or group of
persons) other than Parent or any of its affiliates (a "Third Party") acquires
or would acquire, directly or indirectly, beneficial ownership (as defined in
Rule 13d-3 under the Exchange Act) of more than 20% of the outstanding Shares,
whether from Company or pursuant to a tender offer or exchange offer or
otherwise, (ii) any acquisition or proposed acquisition of Company by a merger
or other business combination (including any so-called "merger of equals" and
whether or not Company or any of its significant subsidiaries, as the case may
be, is the entity surviving any such merger or business combination) or (iii)
any other transaction pursuant to which any Third Party acquires or would
acquire, directly or indirectly, control of assets (including for this purpose
the outstanding equity securities of subsidiaries of Company and any entity
surviving any merger or combination) of Company or any of its subsidiaries for
consideration equal to 20% or more of the fair market value of all Company
Shares on the date prior to the date hereof.
(f) In the event of a breach by Parent or Sub or any of their respective
representations, warranties, obligations or agreements pursuant to this
Agreement or a breach by any Investor of its obligations under the Stockholder
Commitments Parent acknowledges and agrees that Company, on the one hand, and
the holders of the Shares and Options (collectively "Holders"), on the other
hand, will have suffered damages by reason of such breach and shall be entitled
to pursue all remedies at law or in equity as they may have against Parent,
including without limitation the recovery of all damages, costs, and expenses
(including attorneys' fees in connection with this Agreement and any litigation
arising therefrom) incurred in connection therewith (such claims of Company
being hereinafter referred to as "Company Claims" and such claims of the Holders
being hereinafter referred to as "Holder Claims"). In determining damages
resulting from a breach of this Agreement by Parent, the parties expressly agree
that such damages shall include, among other things, (i) as to the Company
Claims, (w) damages arising from disruption from and after the date hereof to
the business of Company (including without limitation loss of personnel and
failure to exploit new projects and loss of opportunities as a result of
restrictions placed on Company's business under this Agreement), (x) costs and
expenses relating to this Agreement and to carrying out the transactions
contemplated hereby, (y) costs of retaining any employees which costs are
reasonably determined to be occasioned by this Agreement and the transactions
relating thereto, including without limitation the bonuses referred to in
Section 6.1(e) and (z) interest, at the highest rate permitted by law, on all of
the foregoing damages from the date of such breach until the date such damages
are paid; and (ii) as to the Holder Claims, (x) damages related to the
diminution of the value of the Holders' respective holdings of Shares or
Options, as the case may be, as compared to the per share purchase price for the
Shares provided for by this Agreement, and (y) interest, at the highest rate
permitted by law, on all of the foregoing damages from the date of such breach
until the date
24
<PAGE>
such damages are paid. Parent agrees that Company may pursue the Holder Claims
on behalf of the Holders.
Section 9.3 Amendment. This Agreement may be amended by the parties
pursuant to a writing adopted by action taken by all of the parties at any time
before the Effective Time; provided, however, that after approval by the
stockholders of Company no amendment may be made which would (i) alter or change
the amount or kinds of consideration to be received by the holders of Shares
upon consummation of the Merger, or (ii) alter or change any of the terms and
conditions of this Agreement if such alteration or change would adversely affect
the holders of the Shares. This Agreement may not be amended except by an
instrument in writing signed by the parties hereto.
Section 9.4 Waiver. At any time before the Effective Time, any party
hereto may (i) extend the time for the performance of any of the obligations or
other acts of the other parties, (ii) waive any inaccuracies in the
representations and warranties contained herein or in any document delivered
pursuant hereto and waive compliance with any of the agreements or conditions
contained herein Any agreement on the part of a party to any such extension or
waiver shall he valid only as against such party and only if set forth in an
instrument in writing signed by such party.
ARTICLE X
GENERAL PROVISIONS
Section 10.1 Survival of Representations, Warranties and Agreements. No
representations, warranties or agreements contained herein shall survive beyond
the Effective Time, except that the representations, warranties or agreements
contained in Sections 3.1, 3.2, 3.3, 4.4, 7.5, 7.7, and 7.10 hereof shall
survive beyond the Effective Time. After the Effective Time, such
representations, warranties and agreements shall be deemed to have been made to,
and may be enforced by, (i) the Holders, in the case of Sections 3.1, 3.2, 3.3
and 4.4, (ii) holders of Options in the case of Section 7.5, (iii) the persons
referred to in Sections 7.7 and Schedule 7.10 in the case of Sections 7.7 and
-------------
7.10, respectively. Prior to such time, such persons shall not be deemed to be
third party beneficiaries of this Agreement.
Section 10.2 Brokers. Company represents and warrants that, (i) except
for Dean Witter Reynolds, Inc., Morgan Stanley & Co. and Cronus Partners, Inc.,
its financial advisors, no broker, finder or financial advisor is entitled to
any brokerage, finder's or other fee or commission in connection with the Merger
or the transactions contemplated by this Agreement based upon arrangements made
by or on behalf of Company and (ii) Company's fee arrangements with such
financial advisors have been disclosed to Parent and Sub.
Section 10.3 Notices. All notices, claims, demands and other
communications hereunder shall be in writing and shall be deemed duly given or
made as follows: (i) if delivered personally, upon receipt; (ii) if sent by
registered or certified mail (postage
25
<PAGE>
prepaid, return receipt requested), upon receipt; (iii) if sent by reputable
overnight air courier (such as Federal Express or DHL), two business days after
mailing; or (iv) if sent by facsimile transmission, with a copy mailed as
provided in clauses (ii) or (iii) above, when transmitted and receipt is
confirmed by telephone. Such notices, claims, demands and other communications
shall be sent to the respective parties at the following addresses (or at such
other address for a party as shall be specified by like notice):
(a) If to Company, to:
Transitional Hospitals Corporation
5110 Sahara Boulevard
Las Vegas, Nevada 89102
Attention: Chief Executive Officer
with a copy to:
Transitional Hospitals Corporation
5110 Sahara Boulevard
Las Vegas, Nevada 89102
Attention: General Counsel
and:
Christensen, Miller, Fink, Jacobs,
Glaser, Weil & Shapiro, LLP
2121 Avenue of the Stars, Suite 1800
Los Angeles, California 90067
Attention: Stephen D. Silbert
(b) if to Parent or Sub, to:
Select Medical Corporation
4718 Old Gettysburg Road
Mechanicsburg, Pennsylvania 17055
Attention: Chief Executive Officer
with a copy to:
Reboul, MacMurray, Hewitt,
Maynard & Kristol
45 Rockefeller Plaza
New York, New York 10111
Attention: Robert A. Schwed, Esq.
26
<PAGE>
Section 10.4 Descriptive Headings. The headings contained in this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement.
Section 10.5 Entire Agreement; Assignment. This Agreement (including the
Schedules, Disclosure Schedules and other documents and instruments referred to
herein) and the Confidentiality Letter (i) constitutes the entire agreement and
supersedes all other prior agreements and understandings, both written and oral
among the parties or any of them, with respect to the subject matter hereof;
(ii) except as set forth in Section 10.1 hereof, is not intended to confer upon
any other person any rights or remedies hereunder; and (iii) shall not be
assigned by operation of law or otherwise.
Section 10.6 Severability. If any provision of this Agreement or the
application of any such provision shall be held invalid, illegal or
unenforceable in any respect by a court of competent jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision
hereof. In lieu of any such invalid, illegal or unenforceable provision, the
parties hereto intend that there shall be added as part of this Agreement a
provision as similar in terms to such invalid, illegal or unenforceable
provision as may be possible and be valid, legal and enforceable.
Section 10.7 Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Nevada without giving
effect to the provisions thereof relating to conflicts of law. Each party
irrevocably and unconditionally consents to submit to the exclusive jurisdiction
of the courts of the State of Nevada located in Clark County, Nevada, and the
courts of the United States of America located in Clark County, Nevada (the
"Nevada Courts"), for any litigation arising out of or relating to this
Agreement and the transactions contemplated hereby (and agrees not to commence
any litigation relating thereto except in the Nevada Courts), waives any
objection to the laying of venue of any such litigation in the Nevada Courts and
agrees not to plead or claim in any Nevada Court that such litigation brought
therein has been brought in an inconvenient forum. The prevailing party in such
litigation shall be entitled to attorneys' fees and costs.
Section 10.8 Specific Performance. The parties hereto agree that
irreparable damage would occur in the event any of the provisions of this
Agreement were not performed in accordance with the terms hereof and that the
parties shall be entitled to specific performance of the terms hereof, in
addition to any other remedy at law or equity.
Section 10.9 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed to be an original but all of which
shall constitute one and the same agreement.
27
<PAGE>
IN WITNESS WHEREOF each of the parties hereto has caused this Agreement to
be executed on its behalf of its officers thereunto duly authorized, all as of
the date first above written.
Attest: SELECT MEDICAL CORPORATION
/s/ By: /s/
- ------------------------ ------------------------------------------
Name: Name:
----------------------------------------
Title: Secretary Title:
---------------------------------------
Attest: SM ACQUISITION CO.
/s/ By: /s/
- ------------------------ ------------------------------------------
Name: Name:
----------------------------------------
Title: Secretary Title:
---------------------------------------
Attest: TRANSITIONAL HOSPITALS CORPORATION
/s/ By: /s/
- ------------------------ ------------------------------------------
Name: Name:
----------------------------------------
Title: Secretary Title:
---------------------------------------
28
<PAGE>
EXHIBIT 99.2
May 2, 1997
Transitional Hospitals Corporation
5110 West Sahara Avenue
Las Vegas, Nevada 89102
Attention: Mr. Richard Conte, Chairman
Gentlemen:
To induce Transitional Hospitals Corporation ("THC") to enter into that
certain Agreement and Plan of Merger dated as of May 2, 1997 (the "Merger
Agreement") with Select Medical Corporation ("Select") and a subsidiary of
Select, the undersigned represent, warrant and covenant as follows:
1. The undersigned hereby commit to provide Select with an aggregate of
$565 million financing in connection with the Merger Agreement. Of the total
financing, $140 million will be provided as equity. Such funds will be
available to consummate the merger or to satisfy any damages for which Select
may be liable under the Merger Agreement.
2. There are no conditions to the aforesaid commitments other than those
conditions to Select's obligations under the Merger Agreement.
3. Select will agree with THC that, upon THC's request, Select will draw
down the commitments as needed to satisfy its aforesaid obligations under the
Merger Agreement. If Select fails to so request the required financing, the
undersigned will honor these commitments to Select upon THC's demand; provided,
however, that if THC obtains a judgment against Select, the undersigned will pay
the amount of such judgment directly to THC.
4. THC is a third party beneficiary of the commitments, and they may not
be modified without THC's approval.
<PAGE>
Mr. Richard Conte
May 2, 1997
Page 2
5. The provisions of Section 10.7 of the Merger Agreement are incorporated
herein by this reference.
Very truly yours,
WELSH, CARSON, ANDERSON & STOWE
By: /S/
---------------------------------------------
GOLDER, THOMA, CRESSEY, RAUNER
By: /S/
---------------------------------------------
FERRER FREEMAN THOMPSON & CO., INC.
By: /S/
---------------------------------------------
